From Volume 46, Issue 10, November 2019 | Pages 986-992
Unfortunately, peri-implant disease is a common clinical finding in patients with dental implants. Whilst preventive and supportive regimens are best practice, many patients still present with signs of peri-implant disease. Treatment options include non-surgical or surgical approaches but there does not appear to be a consensus for management of these challenging conditions. This paper discusses the current management options of peri-implant mucositis and peri-implantitis.
Peri-implant diseases are recognized as being polymicrobial, biofilm-associated inflammatory lesions.1 Peri-implant mucositis is inflammation of peri-implant tissues without associated bone loss, whereas in peri-implantitis there is also loss of supporting clinical attachment and bone. The prevalence of peri-implantitis is reported to affect 10% of implants and 20% of patients over a minimum of 5 years,2 but might range from 6.6%−36.6% of implants and 11.2%−47.1% of patients.3 The prevalence of peri-implant mucositis is higher than that of peri-implantitis, occurring in about 50% of implants and just under 80% of patients.4 Despite this, there does not appear to be any consensus in the treatment approaches for peri-implant diseases.5 This article discusses management options for peri-implant diseases.
Following placement and restoration of any implant-supported prosthesis, patients should be enrolled on a supportive maintenance programme of regular reviews. The aim of this programme is to prevent and allow early detection and management of inflammatory lesions occurring in the peri-implant tissues.5,6
Thank you for visiting Dental Update and reading some of our resources. To read more, please register today. You’ll enjoy the following great benefits:
What's included
